9/11 Victims - New Treatment Advances in Multiple Myeloma
Multiple myeloma has emerged as one of the most common 9/11-related blood cancer diagnoses for people exposed to toxic dust and fumes after the 9/11 attacks. The World Trade Center Health Program (WTCHP) recognizes multiple myeloma as a 9/11-related condition with over 700 cases as of the end of 2023. This prevalence highlights the importance of frequent health monitoring for 9/11 first responders and survivors, including individuals who lived, worked, went to school, or were otherwise present in the area in the months following the attack.